Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-11-26

Clinical Trial Update: A New Eye-based Communication Device for ALS Patients [NA]

View source ↗

Summary

A completed clinical trial evaluated a new eye-based communication device for individuals with amyotrophic lateral sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Amyotrophic Lateral Sclerosis | NA | Status: COMPLETED